Evidence map›Paper›PMID 22470540›Full record

ArticlePloS one2012

No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses.

Harriet C T Groom, Anne Y Warren, David E Neal, Kate N Bishop

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A correlation study ofInfectious agents and cancer · 2019
    Article
  5. Trichomonas vaginalis: a possible foe to prostate cancer.Medical oncology (Northwood, London, England) · 2016
    Article
  6. Review
  7. Article
  8. Article
  9. Infections and inflammation in prostate cancer.American journal of clinical and experimental urology · 2013
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Harriet C T GroomDivision of Virology, MRC National Institute for Medical Research, London, United Kingdom.
Anne Y Warren
David E Neal
Kate N Bishop
University of Cambridge · GB

Funding

Medical Research Council G0500966Medical Research Council G0900871Medical Research Council MC_U117592729Medical Research Council U117592729Wellcome TrustWellcome Trust 084955
6 · The paper itself

Abstract

The prevalence of specific infections in UK prostate cancer patients was investigated. Serum from 84 patients and 62 controls was tested for neutralisation of xenotropic murine leukaemia virus-related virus (XMRV) Envelope. No reactivity was found in the patient samples. In addition, a further 100 prostate DNA samples were tested for XMRV, BK virus, Trichomonas vaginalis and human papilloma viruses by nucleic acid detection techniques. Despite demonstrating DNA integrity and assay sensitivity, we failed to detect the presence of any of these agents in DNA samples, bar one sample that was weakly positive for HPV16. Therefore we conclude that these infections are absent in this typical cohort of men with prostate cancer.

Indexed as

BK VirusPapillomaviridaeTrichomonas vaginalisXenotropic murine leukemia virus-related virusAntibodies, NeutralizingCohort StudiesDNADNA Virus InfectionsHumansMalePolymerase Chain ReactionPolyomavirus InfectionsProstatic NeoplasmsTrichomonas InfectionsTumor Virus InfectionsUnited KingdomAntibodies, NeutralizingDNA

Identifiers

PMID22470540
PMCPMC3314598
OpenAlexW2072563318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.